Publications & Abstracts
Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
The duodenal-jejunal bypass liner (DJBL) is an endoscopic treatment for patients with type 2 diabetes mellitus (T2DM) and (morbid) obesity. The aim...
Safety- and efficacy-outcomes of the duodenal-jejunal bypass liner (DJBL) registry in obese patients with type 2 diabetes
Safety- and efficacy-outcomes of the duodenal-jejunal bypass liner (DJBL) registry in obese patients with type 2 diabetes
Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
Implantation of a duodenal-jejunal endoluminal bypass liner (DJBL) has shown to induce weight loss and to improve metabolic parameters. DJBL is a...
Effects of Duodenal-Jejunal Bypass Liner (EndoBarrier®) on Gastric Emptying in Obese and Type 2 Diabetic Patients
The duodenal-jejunal bypass liner (DJBL) is a promising technique for treating obesity and type 2 diabetes mellitus (T2DM). However, despite...
ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies.
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this...
Safety Experience with the Duodenal-Jejunal Bypass Liner: An Endoscopic Treatment for Diabetes and Obesity
The duodenal-jejunal bypass liner (DJBL) is a new, device-based endoscopic treatment for type 2 diabetes mellitus (T2DM) and obesity.
Statement from the German Diabetic Association (DDG) on the Termination of the “ENDO Trial” Study (FDA Study of the EndoBarrier in Patients with Type 2 Diabetes Mellitus)
On July 30, 2015, GI Dynamics (GID) announced that the clinical study (“Endo Trial”) conducted in the USA would be terminated with...
The Effect of the Endoscopic Duodenal-Jejunal Bypass Liner on Obesity and Type 2 Diabetes Mellitus, A Multicenter Randomized Controlled Trial
Investigate the safety and efficacy of 6 months’ duodenal-jejunal bypass liner (DJBL) treatment in comparison with dietary intervention for...
The Acute Effect of Endobarrier Treatment on Glucose Homeostasis in Obese Uncontrolled Diabetic Subjects
The Endobarrier gastrointestinal liner system (by GI Dynamics®) is an endoscopically-delivered device that offers an alternative to gastric bypass...
Endoscopic, Duodenal-Jejunal Bypass Liner Exerts Robust Improvement in Glycemia and Body Weight in Obese Patients with Type 2 Diabetes
The endoscopically delivered duodenal-jejunal bypass liner (DJBL) exhibits robust metabolic effects in obese subjects with type 2 diabetes...